INTERNATIONAL PATENT: SANLY-HEALTH INCORPORATION IN CELL-TECHNOLOGIES, LTD.BEIJING, 北京三有利康细胞科技有限公司 FILES APPLICATION FOR "USE OF CD146+ MESENCHYMAL STEM CELL IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING CEREBRAL APOPLEXY"

Posted On: 2025-04-28

GENEVA, April 28 -- SANLY-HEALTH INCORPORATION IN CELL-TECHNOLOGIES, LTD.BEIJING (Room 305, 3rd Floor, Building E2, Free Trade Innovation Service Center, Lixian TownDaxing District, Beijing 102600), 北京三有利康细胞科技有限公司 (中国北京市大兴区礼贤镇自贸区创新服务中心E2栋3层305室) filed a patent application (PCT/CN2024/118250) for "USE OF CD146+ MESENCHYMAL STEM CELL IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING CEREBRAL APOPLEXY" on Sep 11, 2024. With publication no. WO/2025/082103, the details related to the pat...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SANLY-HEALTH INCORPORATION IN CELL-TECHNOLOGIES, LTD.BEIJING, 北京三有利康细胞科技有限公司 FILES APPLICATION FOR "USE OF CD146+ MESENCHYMAL STEM CELL IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING CEREBRAL APOPLEXY"